Correlation Between 23Andme Holding and Enliven Therapeutics
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Enliven Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Enliven Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and Enliven Therapeutics, you can compare the effects of market volatilities on 23Andme Holding and Enliven Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Enliven Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Enliven Therapeutics.
Diversification Opportunities for 23Andme Holding and Enliven Therapeutics
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between 23Andme and Enliven is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Enliven Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enliven Therapeutics and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Enliven Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enliven Therapeutics has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Enliven Therapeutics go up and down completely randomly.
Pair Corralation between 23Andme Holding and Enliven Therapeutics
Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the Enliven Therapeutics. In addition to that, 23Andme Holding is 2.68 times more volatile than Enliven Therapeutics. It trades about -0.22 of its total potential returns per unit of risk. Enliven Therapeutics is currently generating about -0.16 per unit of volatility. If you would invest 2,852 in Enliven Therapeutics on August 30, 2024 and sell it today you would lose (311.00) from holding Enliven Therapeutics or give up 10.9% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
23Andme Holding Co vs. Enliven Therapeutics
Performance |
| Timeline |
| 23Andme Holding |
| Enliven Therapeutics |
23Andme Holding and Enliven Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 23Andme Holding and Enliven Therapeutics
The main advantage of trading using opposite 23Andme Holding and Enliven Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Enliven Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enliven Therapeutics will offset losses from the drop in Enliven Therapeutics' long position.| 23Andme Holding vs. IDEXX Laboratories | 23Andme Holding vs. Twist Bioscience Corp | 23Andme Holding vs. Guardant Health | 23Andme Holding vs. Agilent Technologies |
| Enliven Therapeutics vs. Pmv Pharmaceuticals | Enliven Therapeutics vs. Cullinan Oncology LLC | Enliven Therapeutics vs. Immuneering Corp | Enliven Therapeutics vs. Aerovate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |